River & Mercantile Asset Management LLP Makes New Investment in Teladoc Health Inc (NYSE:TDOC)

River & Mercantile Asset Management LLP acquired a new position in shares of Teladoc Health Inc (NYSE:TDOC) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 46,715 shares of the health services provider’s stock, valued at approximately $3,102,000. River & Mercantile Asset Management LLP owned about 0.06% of Teladoc Health as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of TDOC. CENTRAL TRUST Co boosted its stake in shares of Teladoc Health by 82.6% during the second quarter. CENTRAL TRUST Co now owns 378 shares of the health services provider’s stock worth $27,000 after buying an additional 171 shares during the period. Seelaus Asset Management LLC boosted its stake in shares of Teladoc Health by 5.9% during the second quarter. Seelaus Asset Management LLC now owns 4,050 shares of the health services provider’s stock worth $269,000 after buying an additional 225 shares during the period. Cornerstone Advisors Inc. boosted its stake in shares of Teladoc Health by 187.0% during the second quarter. Cornerstone Advisors Inc. now owns 465 shares of the health services provider’s stock worth $31,000 after buying an additional 303 shares during the period. FTB Advisors Inc. boosted its stake in shares of Teladoc Health by 82.5% during the second quarter. FTB Advisors Inc. now owns 719 shares of the health services provider’s stock worth $47,000 after buying an additional 325 shares during the period. Finally, Meridian Wealth Management LLC acquired a new stake in shares of Teladoc Health during the second quarter worth about $27,000.

In other news, President Peter A. Mcclennen sold 13,753 shares of Teladoc Health stock in a transaction that occurred on Monday, July 15th. The shares were sold at an average price of $70.99, for a total transaction of $976,325.47. Following the completion of the sale, the president now directly owns 29,412 shares in the company, valued at approximately $2,087,957.88. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Lewis Levy sold 675 shares of Teladoc Health stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $60.00, for a total transaction of $40,500.00. Following the sale, the insider now owns 4,805 shares of the company’s stock, valued at $288,300. The disclosure for this sale can be found here. In the last 90 days, insiders sold 78,056 shares of company stock valued at $5,396,434. 3.14% of the stock is owned by insiders.

NYSE:TDOC traded down $1.06 during mid-day trading on Tuesday, reaching $66.66. The stock had a trading volume of 1,426,482 shares, compared to its average volume of 1,506,335. The company has a debt-to-equity ratio of 0.43, a quick ratio of 7.56 and a current ratio of 7.56. The firm has a market capitalization of $4.96 billion, a price-to-earnings ratio of -46.29 and a beta of 1.36. Teladoc Health Inc has a twelve month low of $42.08 and a twelve month high of $89.05. The business has a 50 day simple moving average of $63.52 and a 200 day simple moving average of $61.81.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.41) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.40) by ($0.01). The firm had revenue of $130.30 million during the quarter, compared to analyst estimates of $129.54 million. Teladoc Health had a negative net margin of 21.85% and a negative return on equity of 10.64%. Teladoc Health’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.40) EPS. As a group, sell-side analysts expect that Teladoc Health Inc will post -1.56 earnings per share for the current year.

Several equities research analysts have recently weighed in on the stock. SunTrust Banks increased their target price on shares of Teladoc Health to $80.00 and gave the stock a “positive” rating in a research note on Tuesday, August 6th. Oppenheimer set a $83.00 target price on shares of Teladoc Health and gave the stock a “buy” rating in a research note on Friday, September 6th. Piper Jaffray Companies set a $87.00 target price on shares of Teladoc Health and gave the stock a “buy” rating in a research note on Friday, August 16th. Jefferies Financial Group reiterated a “buy” rating and set a $95.00 target price on shares of Teladoc Health in a research note on Tuesday, July 2nd. Finally, Deutsche Bank assumed coverage on shares of Teladoc Health in a research note on Thursday, September 12th. They set a “buy” rating and a $76.00 target price for the company. Three investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $79.20.

Teladoc Health Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Further Reading: Ex-Dividend

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.